Transcatheter heart valve - smaller and more durable
DuraBiotech has patented heart valve design technology developed at UConn that improves transcatheter heart valve durability. The company’s world leading platform technologies on heart valve computer modeling and design have resulted in innovative heart valve device designs and treatment strategies for high-risk patients with severe aortic stenosis and mitral regurgitation, as well as for pediatric patients who have congenital pulmonary anomalies. Our products feature effective and durable devices, safer and easier delivery procedure, and reduced operating and post-operative recovery time.
Wei Sun, Founder & CSO
Thuy Pham, CTO